Apellis Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
7 result(s) found, displaying 1 to 7
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SYFOVRE pegcetacoplan 15 mg/0.1 mL solution for injection vial.
-
Prescription medicine registrationActive ingredients: pegcetacoplan.
-
Australian Public Assessment Report (AusPAR)New AusPAR for Empaveli (pegcetacoplan) for the treatment of adult patients with paroxysmal nocturnal haemoglobinuria.
-
Prescription medicine decision summaryTGA decision: Empaveli (pegcetacoplan) is approved to treat adult patients with paroxysmal nocturnal haemoglobinuria (PNH).
-
Prescription medicine registrationActive ingredients: pegcetacoplan.
-
Prescription medicine registrationActive ingredients: pegcetacoplan.
-